fashion -WSS

fashion

author：fashion 2025-09-29 21:13:27 - browse：3532

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Biden report: The neurospychology of memory and aging

Wikipedia

WSS

The Karikó problem: Lessons for funding basic research

Medicare Advantage proposed rates disappoint insurers

Study points to new risk in gene therapy death of Terry Horgan

Stop Congress from blocking public access to science

The Karikó problem: Lessons for funding basic research

Will an HIV vaccine ever be a reality?

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Cancer drug shortages should be causing more outrage

Vaccine advisory panel ACIP left half staffed by HHS

How one medical school became remarkably diverse

The Readout: Gilead, Bernie Sanders, and other pharma news

Duchenne breakthrough therapy leaves behind pioneering families

With Roe v Wade overturned, abortion providers work to adapt

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: How biotech is using artificial intelligence

After affirmative action ruling, medical educators look to 'holistic review'

BioAge raises $170M for combination therapy with Zepbound

knowledge

Medical mystery: When a cough is not just a cough

Lawsuit highlights wrinkle for disputes over surprise medical bills

Flu, Covid vaccination rates decline, new survey data show

Vaccine advisory panel ACIP left half staffed by HHS

KalVista pill reduced swelling 'attacks' caused by genetic disease

Medicare Advantage proposed rates disappoint insurers

focus

Wikipedia

leisure time

focus